Resveratrol inhibits type II phosphatidylinositol 4-kinase: A key component in pathways of phosphoinositide turn over

Biochemical Pharmacology

Volumn 70, Issue 7, 2005, Pages 1048-1055

  Srivastava, Rupa ^a   Ratheesh, Aparna ^b   Gude, Rajiv K ^b   Rao, K V K ^b   Panda, Dulal ^a   Subrahmanyam, Gosukonda ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cell adhesion; Signal transduction; T lymphocytes

Indexed keywords

ARSENOSOBENZENE; FIBRONECTIN; MATRIGEL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; COATED PARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; HEART PROTECTION; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; LEUKEMIA CELL LINE; LYMPHOCYTIC INFILTRATION; NUCLEOTIDE SEQUENCE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; CELL ADHESION; CELL LINE; CLONING, MOLECULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; JURKAT CELLS; PHOSPHATIDYLINOSITOLS; STILBENES;

EID: 24344454365     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.07.003     Document Type: Article

References (44)

1. P. Langcake, and R.J. Pryce A new class of phytoalexins from grapevines Experientia 33 1977 151 152
2. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, and C.W. Beecher Cancer chemo preventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
3. L. Frémont Biological effects of resveratrol Life Sci 66 2000 663 673
4. J.M. Pezzuto Resveratrol: a whiff that induces a biologically specific tsunami Cancer Biol Ther 3 2004 889 890
5. J.M. Wu, Z.R. Wang, T.C. Hsieh, J.L. Bruder, J.G. Zou, and Y.Z. Huang Mechanism of cardio protection by resveratrol, a phenolic antioxidant present in red wine Int J Mol Med 8 2001 3 17
6. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Lett 421 1998 277 279
7. F.D. Ragione, V. Cucciolla, A. Borriello, V.D. Pietra, L. Racioppi, and G. Soldati Resveratrol arrests the cell division cycle at S/G2 phase transition Biochem Biophys Res Commun 250 1998 53 58
8. R.S. Haworth, and M. Avkiran Inhibition of protein kinase D by resveratrol Biochem Pharmacol 62 2001 1647 1651
9. N. Ahmad, V.M. Adhami, F. Afaq, D.K. Feyes, and H. Mukhtar Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells Clin Cancer Res 7 2001 1466 1473
10. F. Wolter, B. Akoglu, A. Clausnitzer, and J. Stein Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines J Nutr 131 2001 2197 2203
11. K.P. Bhat, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol Ann N Y Acad Sci 957 2002 210 219
12. S.J. Slater, J.L. Seiz, A.C. Cook, B.A. Stagliano, and C.J. Buzas Inhibition of protein kinase C by resveratrol Biochim Biophys Acta 1637 2003 59 69
13. Y. Wang, B. Wang, J. Cheng, L. Yang, Z.L. Liu, and K. Balan FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene Biochem Pharmacol 69 2005 249 254
14. T. Hsieh, D. Halicka, X. Lu, J. Kunicki, J. Guo, and Z. Darzynkiewicz Effects of resveratrol on the G(0)-G(1) transition and cell cycle progression of mitogenically stimulated human lymphocytes Biochem Biophys Res Commun 297 2002 1311 1317
15. T. Balla Pharmacology of phosphoinositides, regulators of multiple cellular functions Curr Pharm Des 7 2001 475 477
16. L.M. Heilmeyer Jr., G. Vereb Jr., G. Vereb, A. Kakuk, and I. Szivak Mammalian phosphatidylinositol 4-kinases IUBMB Life 55 2003 59 65
17. A.Z. Fernandis, and G. Subrahmanyam Concanavalin A modulates tyrosine phosphorylation and activation of a type II phosphatidylinositol 4-kinase in rat splenic lymphocytes Mol Immunol 35 1998 935 941
18. A.Z. Fernandis, and G. Subrahmanyam Protein tyrosine phosphorylation activates rat splenic type II phosphatidylinositol 4-kinase in vitro FEBS Lett 441 1998 432 436
19. A.Z. Fernandis, and G. Subrahmanyam Tyrosyl phosphorylation and activation of a type II phosphatidylinositol 4-kinase by p56(lck) in Concanavalin A stimulated rat splenic lymphocytes Mol Immunol 37 2000 273 280
20. A.Z. Fernandis, R. Srivastava, R.K. Sinha, and G. Subrahmanyam A type II phosphatidylinositol 4-kinase associates with T cell receptor zeta chain in Con A stimulated splenic lymphocytes through tyrosyl phosphorylation-dependent mechanisms Mol Immunol 42 2005 561 568
21. Srivastava R, Sinha KR, Subrahmanyam G. Type II PtdIns 4-kinase β interacts with TCR-CD3 zeta chain. Mol Immunol, 2005, doi:10.1016/j.molimm.2005. 03.009.
22. M.K. Santra, and D. Panda Detection of an intermediate during unfolding of bacterial cell division protein FtsZ: loss of functional properties precedes the global unfolding of FtsZ J Biol Chem 278 2003 21336 21343
23. R.P. Gude, M.M. Binda, H.L. Presas, A.J. Klein-Szanto, and R.D. Bonfil Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline J Biomed Sci 6 1999 133 141
24. F. Berditchevski, K.F. Tolias, K. Wong, C.L. Carpenter, and M.E. Hemler A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase J Biol Chem 272 1997 2595 2598
25. K. Barkalow, W. Witke, D.J. Kwiatkowski, and J.H. Hartwig Coordinated regulation of platelet actin filament barbed ends by gelsolin and capping protein J Cell Biol 134 1996 389 399
26. C.L. Carpenter, and L.C. Cantley Phosphoinositide kinases Curr Opin Cell Biol 8 1996 153 158
27. K.R. Auger, and L.C. Cantley Novel polyphosphoinositides in cell growth and activation Cancer Cells 3 1991 263 270
28. J. Garcia-Garcia, V. Micol, A. de Godos, and J.C. Gomez-Fernandez The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity Arch Biochem Biophys 372 1999 382 388
29. V. Granados-Soto Pleiotropic effects of resveratrol Drug News Perspect 16 2003 299 307
30. M. Murias, N. Handler, T. Erker, K. Pleban, G. Ecker, and P. Saiko Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship Bioorg Med Chem 12 2004 5571 5578
31. J.K. Kundu, and Y.J. Surh Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets Mutat Res 555 2004 65 70
32. A.F. Quest, and R.M. Bell The regulatory region of protein kinase C gamma. Studies of phorbol ester binding to individual and combined functional segments expressed as glutathione S-transferase fusion proteins indicate a complex mechanism of regulation by phospholipids, phorbol esters, and divalent cations J Biol Chem 269 1994 20000 20002
33. A.F. Quest, E.S. Bardes, and R.M. Bell A phorbol ester binding domain of protein kinase C gamma. Deletion analysis of the Cys2 domain defines a minimal 43-amino acid peptide J Biol Chem 269 1994 2961 2970
34. S.S. Singh, A. Chauhan, H. Brockerhoff, and V.P. Chauhan Interaction of protein kinase C and phosphoinositides: regulation by polyamines Cell Signal 6 1994 345 353
35. U.G. Haider, D. Sorescu, K.K. Griendling, A.M. Vollmar, and V.M. Dirsch Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells Mol Pharmacol 62 2002 772 777
36. E. Pozo-Guisado, M.J. Lorenzo-Benayas, and P.M. Fernandez-Salguero Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation Int J Cancer 109 2004 167 173
37. Haider UG, Roos TU, Kontaridis MI, Neel BG, Sorescu D, Griendling KK, et al. Resveratrol inhibits angiotensin II- and EGF-mediated Akt activation role of Gab 1 and Shp2. Mol Pharmacol 2005;68:41-8.
38. A.M. Mirza, S. Gysin, N. Malek, K. Nakayama, J.M. Roberts, and M. McMahon Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT Mol Cell Biol 24 2004 10868 10881
39. N. Gao, D.C. Flynn, Z. Zhang, X.S. Zhong, V. Walker, and K.J. Liu G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells Am J Physiol Cell Physiol 287 2004 C281 C291
40. A.H. Cory, L. Somerville, and J.G. Cory Blockage of cyclin cdk's, PKC and phosphoinositol 3-kinase pathways leads to augmentation of apoptosis in drug-resistant leukemia cells: evidence for interactive effects of flavopiridol LY 294002 roscovitine, wortmannin and UCN-01 Anticancer Res 25 2005 101 106
41. G.Z. Rassidakis, M. Feretzaki, C. Atwell, I. Grammatikakis, Q. Lin, and R. Lai Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma Blood 105 2005 827 829
42. J. Blenis Signal transduction via the MAP kinases: proceed at your own RSK Proc Natl Acad Sci USA 90 1993 5889 5892
43. C.J. Jensen, M.B. Buch, T.O. Krag, B.A. Hemmings, S. Gammeltoft, and M. Frodin 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1 J Biol Chem 274 1999 27168 27176
44. S. Suer, A. Sickmann, H.E. Meyer, F.W. Herberg, and L.M. Heilmeyer Jr. Human phosphatidylinositol 4-kinase isoform PI4K92. Expression of the recombinant enzyme and determination of multiple phosphorylation sites Eur J Biochem 268 2001 2099 2106